Bridgewater, NJ, United States of America

William Wire

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Genzyme Corporation. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 15.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of William Wire

Introduction

William Wire is an accomplished inventor based in Bridgewater, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address critical health issues.

Latest Patents

William Wire holds a patent for "Arylamides and methods of use thereof." This patent relates to substituted aryl amide compounds, which are described by a specific formula. The disclosure includes pharmaceutically acceptable salts and pharmaceutical preparations of these compounds. Furthermore, it outlines the use of such compounds in treating diseases and conditions mediated by deficient CFTR activity, with a particular focus on cystic fibrosis.

Career Highlights

William Wire is associated with Genzyme Corporation, a leading biotechnology company known for its innovative approaches to medicine. His work at Genzyme has allowed him to contribute to advancements in treatments for various diseases.

Collaborations

Throughout his career, William has collaborated with notable colleagues, including Mark C Munson and Martin Smrcina. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in the pharmaceutical industry.

Conclusion

William Wire's contributions to the field of pharmaceuticals through his patent and work at Genzyme Corporation highlight his commitment to improving health outcomes. His innovative approach continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…